BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10700860)

  • 21. Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia.
    Takeshita A; Naito K; Shinjo K; Sahara N; Matsui H; Ohnishi K; Beppu H; Ohtsubo K; Horii T; Maekawa M; Inaba T; Ohno R
    Cancer Genet Cytogenet; 2004 Jul; 152(1):56-60. PubMed ID: 15193442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome.
    Glassman AB; Hayes KJ
    Ann Clin Lab Sci; 2003; 33(3):285-8. PubMed ID: 12956443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15).
    Nakamura T; Yamazaki Y; Hatano Y; Miura I
    Blood; 1999 Jul; 94(2):741-7. PubMed ID: 10397741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. t(7;11) and trilineage myelodysplasia in acute myelomonocytic leukemia.
    Inaba T; Shimazaki C; Yoneyama S; Hirai H; Kikuta T; Sumikuma T; Sudo Y; Yamagata N; Ashihara E; Goto H; Fujita N; Nakagawa M
    Cancer Genet Cytogenet; 1996 Jan; 86(1):72-5. PubMed ID: 8616792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous occurrence of der(1;7)(q10;p10) and t(14;18)(q32;q21) in non-Hodgkin's lymphoma: der(1;7) will appear as a secondary change in lymphoid neoplasia.
    Hsiao HH; Sashida G; Ito Y; Tachino M; Beppu H; Ohyashiki K
    Leuk Lymphoma; 2005 Jun; 46(6):949-50. PubMed ID: 16019545
    [No Abstract]   [Full Text] [Related]  

  • 27. Ph+ acute myelogenous leukemia with t(7;11)(p15;p15) and clonal evolution in relapse after bone marrow transplantation.
    Miura I; Nishinari T; Hashimoto K; Nimura T; Takatsu H; Niitsu H; Hirokawa M; Kuwayama A; Nishimura S; Miura AB
    Acta Haematol; 1993; 90(3):148-50. PubMed ID: 8291375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome.
    Nishiyama M; Arai Y; Tsunematsu Y; Kobayashi H; Asami K; Yabe M; Kato S; Oda M; Eguchi H; Ohki M; Kaneko Y
    Genes Chromosomes Cancer; 1999 Nov; 26(3):215-20. PubMed ID: 10502319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
    Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
    J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
    Santhosh-Kumar CR; Ajarim DS; Shipkey FD
    Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute lymphoblastic leukemia with t(1;11)(p32;q23) in a patient treated for osteogenic sarcoma.
    Pinto LI; Marczyk FF; Brunetto AL
    Pediatr Hematol Oncol; 1998; 15(1):93-5. PubMed ID: 9509513
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation.
    Wei S; Wang S; Qiu S; Qi J; Mi Y; Lin D; Zhou C; Liu B; Li W; Wang Y; Wang M; Wang J
    Leuk Res; 2013 Sep; 37(9):1010-5. PubMed ID: 23800796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma.
    Salles MT; Neyra O; Taja L; Cervantes G; Gagnière M; Cerrillo M; Mohar A; Osornio A; Reynoso E; Gorodezky G
    Cancer Genet Cytogenet; 1992 Mar; 59(1):80-3. PubMed ID: 1372839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
    Yamamoto K; Nagata K; Morita Y; Hamaguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangement.
    Lauw MIS; Qi Z; Eversmeyer L; Prakash S; Wen KW; Yu J; Monaghan SA; Aggarwal N; Wang L
    Hum Pathol; 2022 May; 123():11-19. PubMed ID: 35167894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
    Shikoshi K; Shikoshi K; Niitsu N; Takada M; Umeda M
    Nihon Ronen Igakkai Zasshi; 1994 Jun; 31(6):468-71. PubMed ID: 8078212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
    Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD
    Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Fisher RI; Miller TP; Dana BW; Jones SE; Dahlberg S; Coltman CA
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):21-5. PubMed ID: 2438778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
    Miyata A; Deguchi S; Fujita M; Kikuchi T; Honda K
    Rinsho Ketsueki; 1996 May; 37(5):448-51. PubMed ID: 8691593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.